Skip to main content
ACH
NYSE Trade & Services

Accendra Health Details $1.5B Debt Optimization, Reports Q1 Loss Amid Revenue Decline

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Neutral
Importance info
9
Price
$3.96
Mkt Cap
$302.694M
52W Low
$1.84
52W High
$9.55
52W Position info
115% above low
Off High info
59% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ACH has more than doubled off its 52-week low of $1.84.

Summary

Accendra Health reported a Q1 loss and declining revenue, but the filing's most critical aspect is the detailed plan for a $1.5 billion debt restructuring, which secures near-term liquidity by extending maturities at higher interest rates.


Key Events · Financing and Capital Events · ACH

  • Balance Sheet Optimization

    The company announced commitments to refinance over $1.5 billion in debt, including extending the Term Loan A and Revolving Credit Facility maturities, which were previously classified as current liabilities.

  • New Debt Terms

    The restructuring involves exchanging existing notes for new 9.000% senior secured first lien notes due 2032 and 9.750% senior secured second lien notes due 2033.

  • Q1 Financial Performance

    Reported a net loss of $6.47 million, an improvement from the prior year's $24.98 million net loss (which included discontinued operations). However, loss from continuing operations worsened to $6.47 million from $3.81 million year-over-year.

  • Revenue Decline

    Net revenue decreased by 6.8% to $627.78 million, primarily due to terminated commercial payor contracts.


Analysis · ACH · Trade & Services

Accendra Health's first-quarter report highlights a critical balance sheet optimization transaction, securing commitments to refinance over $1.5 billion in debt. This move addresses significant near-term maturities, including the Term Loan A and Revolving Credit Facility, which were classified as current liabilities. While averting an immediate liquidity crisis, the restructuring involves new senior secured notes with higher interest rates (9.000% and 9.750%). Operationally, the company reported a 6.8% revenue decline and an increased loss from continuing operations, signaling ongoing challenges despite the crucial debt relief.

How filings like this one have moved

In the 30 days to Oct 23, 2026, 46% of the 276 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.70%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACH was trading at $3.96 on NYSE in the Trade & Services sector, with a market capitalization of approximately $302.7M. The 52-week trading range was $1.84 to $9.55. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACH - Latest Insights

ACH
Oct 19, 2026, 5:16 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.210
Real-time Price: $0.2173 info
Change: +$0.0073 (+3%) info
Market Cap: $16.711M info
ACH
Oct 09, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $0.428
Real-time Price: $0.2173 info
Change: -$0.2107 (-49%) info
Market Cap: $16.711M info
ACH
Sep 17, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $0.2173 info
Change: -$0.8432 (-80%) info
Market Cap: $16.711M info
ACH
Sep 11, 2026, 4:30 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $1.08
Real-time Price: $0.2173 info
Change: -$0.8627 (-80%) info
Market Cap: $16.711M info
ACH
Aug 10, 2026, 11:15 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $0.2173 info
Change: -$1.09 (-83%) info
Market Cap: $16.711M info